Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3215 studies found for:    Open Studies | radiotherapy
Show Display Options
Rank Status Study
21 Recruiting Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Stereotactic Body Radiotherapy (SBRT);   Radiation: Conventional Radiotherapy (CRT)
22 Not yet recruiting Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid
Condition: Prostatic Adenocarcinoma
Interventions: Radiation: Moderate hypofractionated radiotherapy;   Radiation: Stereotactic radiotherapy
23 Unknown  Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract
Condition: Squamous Cell Carcinoma
Interventions: Radiation: single-fraction radiotherapy with concomitant 5FU and Hydrea;   Radiation: hyperfractionated radiotherapy with concomitant Cetuximab
24 Unknown  Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection
Condition: Brain Metastases
Interventions: Radiation: stereotactic body radiotherapy (SBRT);   Radiation: Whole-Brain Radiotherapy (WBRT)
25 Recruiting Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
Condition: Lung Cancer
Intervention: Radiation: Stereotactic Body Radiotherapy (SABR)
26 Recruiting IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Radiation: Concurrent chemoradiotherapy(CCRT);   Radiation: Stereotactic Radiotherapy(SBRT);   Drug: S-1
27 Recruiting An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: radiation therapy
28 Unknown  Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial
Condition: Gastric Cancer
Intervention: Radiation: Palliative Radiotherapy
29 Recruiting Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Radiation: carbon-ion radiotherapy alone;   Radiation: proton plus carbon-ion radiotherapy
30 Recruiting Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases
Conditions: Non-small-cell Lung Cancer;   Brain Metastases
Interventions: Drug: Erlotinib;   Radiation: concurrent brain radiotherapy;   Radiation: secondary brain radiotherapy
31 Recruiting A Randomized Phase III Study of Palliative Radiation of Advanced Central Tumors With Intentional Avoidance of the Esophagus
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: Conventional radiotherapy;   Radiation: Esophageal-Sparing Intensity-Modulated Radiotherapy
32 Recruiting "Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL
Condition: Treatment Refusal
Interventions: Drug: P-CHOP;   Radiation: Radiotherapy
33 Unknown  Carbon Ion Radiotherapy for Recurrent Gliomas
Condition: Glioma
Interventions: Radiation: Carbon Ion Radiotherapy;   Radiation: Fractionated Stereotactic Radiotherapy (FSRT)
34 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
35 Recruiting Treatment of Natural Killer/T Cell Lymphoma-I/II
Condition: Nasal and Nasal-type NK/T-cell Lymphoma
Interventions: Other: DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase);   Other: VIPD(cisplatin,Etoposide,Ifosfamide, dexamethasone,Mesna);   Other: gemcitabine,pegaspargase,cisplatin,dexamethasone;   Other: cisplatin,Etoposide,Ifosfamide,dexamethasone,Mesna;   Radiation: Radiotherapy
36 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Drug: 18F-Fluoromisonidazole;   Drug: Carboplatin;   Procedure: Computed Tomography;   Radiation: External Beam Radiation Therapy;   Drug: Fludeoxyglucose F-18;   Radiation: Image-Guided Adaptive Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography
37 Not yet recruiting Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
Condition: Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Interventions: Radiation: Carbon ions therapy;   Radiation: Advanced external radiotherapy by Xrays or protons
38 Recruiting Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
39 Recruiting S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Conditions: Esophageal Cancer;   Chemoradiation
Interventions: Radiation: Radiotherapy 54 Gy;   Radiation: Radiotherapy 60 Gy;   Drug: S-1
40 Recruiting Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Stage IB2 Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Vaginal Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Radiation: Radiation Therapy;   Drug: Triapine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years